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Transpiacental Transport of Lead
by Robert A. Goyer*
Neurotoxicity is the major health effect from exposure to lead for infants and young children, and there
is current concern regarding possible toxic effects oflead on the child while in utero. There is no placental-
fetal barrierto leadtransport. Maternal andfetalblood leadlevels are nearlyidentical, so leadpassesthrough
the placenta unencumbered. Lead hasbeen measured in the fetal brain as early as the endofthe firsttrimester
(13 weeks). There is asimilarrate ofincrease in brain size and leadcontent throughout pregnancy in the fetus
ofmothers in the general population, so concentration oflead probably does not differ greatly during gesta-
tion unless exposure ofthe mother changes. Cell-specific sensitivity to the toxic effects oflead, however, may
be greater the younger the fetus. Lead toxicity to the nervous system is characterized by edema or swelling
ofthe brain due to alteredpermeabilityofcapillary endothelial cells. Experimental studies suggest that imma-
ture endothelial cells forming the capillaries ofthe developing brain are less resistant to the effects of lead,
permitting fluid and cations including lead to reach newly formed components of the brain, particularly
astrocytes and neurons. Also, the ability ofastrocytes and neurons to sequester lead in the fonn oflead pro-
tein complexes occurs only in the later stages of fetal development, permitting lead in maturing brain cells
to interact with vital subcellular organelles, particularly mitochondria, which are the major cellular energy
source. Intracellular lead alsoaffectsbindingsitesforcalcium which, in turn, mayaffectnumerous cell functions
including neurotransmitter release.
Introduction
Life in utero as a developing embryo and fetus may be
the most vulnerable period for lead toxicity to occur. It is
clear from research that has been reported in the past few
years that neurotoxicity from lead occurs from exposure to
levels not previously thought to be toxic (1-4) and that the
perinatal period may be a particularly vulnerable time for
neurotoxicity to occur (5,6). However, a number ofspecific
questions need to be further addressed such as the mech-
anisms and factors affecting transplacental transport oflead
from mother to fetus, possible effects on normal placental
function, and, finally, the affinity of lead for the developing
nervous system and the nature of early biochemical or
pathological effects.
The information currently available to answerthese ques-
tions is limited (7,8). The placenta is generally described
as the interface between the mother and the outside world
or environment and the developing fetus. Substances cross
the placenta by a number of transport mechanisms as in
otherbody tissues, simple diffusion for small molecules, acti-
vated transport for larger molecules with molecular weight
less than 400,000, and pinocytosis for macromolecules. The
principal function, of course, is to provide a conduit for the
nourishment ofthe developing fetus. The placenta has mech-
anisms that enhance the transport ofthose substances that
are needed and restricts the entry ofthose substances that
are toxic or otherwise harmful. These mechanisms are
related to hormonal influences, some oxidative reactions,
mostly nonenzymatic, andperhaps, mostimportantly, umbi-
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lical cord or fetal blood flow. The placenta provides a route
for excretion oftoxic wastes. This is, admittedly, a simplistic
view, but it is in this context that the role of the placenta
in fetal exposure to lead needs to be considered. Most
studies to date have concerned essential organic nutrients
and macromolecules. Pharmacologists have understandably
a large interest in drug and chemical metabolism in the pla-
centa, but there has been relatively little study to date of
the mechanisms fortransport ofessential trace metals apart
from calcium and iron and verylittle study oftransplacental
transport of toxic metals per se, including lead, cadmium,
and mercury.
The purpose of this paper is to provide an overview of
the mechanisms for transplacental transport oflead and fac-
tors that may influence it. There is also need to comment
on possible experimental models for further study of lead
effects in utero. The availability of human fetal tissue for
research is very limited, and there is no ideal animal surro-
gate. The primate might be the best choice for obvious
reasons, buthere there are constraints; high costis amajor
concern. For this reasonthe rat may be a satisfactory alter-
native, atleast in terms ofstudying mechanisms oftransport
and some aspects of intrauterine toxicity.
The fetal-maternal barrier in the mature rat placenta is
very similar anatomically to that of the human placenta
(Fig. 1) (9). Both are hemochorial placentas, thatis, the fetal
chorionic vill bathe in lacunae of maternal blood (Fig. 2).
In the humanplacenta, the villous capilaryis separated from
maternal blood by three layers or cells, the capillary endo-
thelial cell, an interstitial or connective tissue layer, and a
layer ofcytotrophoblasts. Syncytiotrophoblasts do not form
a continuous layer but are intermittent. The layers of the
chorionic villus in the rat are similar but differ by theR. A. GOYER
presence ofan additional layer ofcytotrophoblasts. The pho-
tomicrograph in Figure 2 shows the relationship of fetal -
capillaries to endometrial tissue which contains a rich
capillary bed opening into lacunae of maternal blood. In E W i
Figures 3 and 4 and the ultrastructural components ofthe
cells composing the chorionic villus canbe seen. Intracellular
vacuoles functionally involved in transport ofnutrients and
macromolecules are common to endothelial cells, cytotro-
phoblasts, and syncytiotrophoblasts.
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FIGURE 1. Comparison of chorionic villus of mature human placenta and rat
placenta. The fetal maternal-barrier in the humanchorionic villus consists
ofthree layers ofcells, fetal endothelial cells, interstitial cells, and a single
layer ofcytotrophoblasts. The outer syncytiotrophoblasts do not form a
complete layer. The rodent (rat or mouse) chorionic villus differs in that
itcontains twolayers ofcytotrophoblasts. Both human androdentchorionic
villi bathe in lacunae ofmaternal blood. The endometrial basal plate is char-
acterized by decidual cells as well as maternal blood vessels. j'
4;-' t a, *FIGURE 4. High magnification electron photomicrograph of rat placenta show-
ing a thinlayer ofendothelial cells (EC), cytoplasmlining the villous capillary,
twolayers ofcytotrophoblasts (CT), and a narrowirregularportionofsyn-
cytiotrophoblast (ST) lining maternal lacunar (L) blood space.
£0: s t ilElectron microscopic studies and immunohistochemical
analyses have demonstrated that the cytotrophoblast is
9 {[ ^ .* i primarily the germinative cell layer, whereas the syncytio-
trophoblast is the secretory layer as evidencedby hormone
content (steroid andpeptide hormones) and the numerous
mitochondria as energy source to support the high level
ofmetabolic activity as well as transport function (9). The
syncytiotrophoblast has been shown to be the site ofmetal-
lothionein synthesis, aprotein thatbinds cadmium and may
FIGURE 2. Light microscopic photograph of Figure 3. Mature rat placenta also enhance transport of the essential trace metals zinc
showing fetal capillaries (FC) in villi within lacunae (L) ofmaternal blood. and copper (7,10).
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'Fable 1. Transplacental transport of toxic metals.
Number of Blood levels
Metal samples Mother Cord Reference
Lead, ng/mL 19 40.4 + 18.2 37.1 ± 13.5 (11)
76.1 + 23.5 67.7 ± 41.0 (Nakano and Kuroso, unpublished)
64.8 + 18.8 58.4 ± 20.2 (12)
Cadmium, ng/mL 19 1.1 ± 0.9 0.4 ± 0.2 (11)
Total mercury, ng/mL 231 19 + 36 30 ± 62 (13)
Methyl mercury, ng/mL 226 9 + 5 14 ± 9 (13)
Iron, ppm 234 ± 102 392 ±166 (13)
Table 1 compares concentrations oftoxic metals between
mother's blood and cord blood levels for several metals.
There have been several studies comparing maternal and
fetal blood lead levels, some of the more recent are cited.
All the studies show good maternal-fetal correlation (r =
0.77 to 0.80) with cord blood equal to or slightly lower than
maternal blood lead levels. It appears, therefore, that there
is no protective barrier for the fetus from exposure to lead
from mother's blood. But for some metals the placenta is
abarrier, and forothers it seems to enhance transport. Cad-
mium maybe 40 to 50% lowerinfetalbloodthan in mother's
blood, and the protective barrier is thought to be related
to metallothionein binding. The newborn is relatively spared
cadmium exposure and is usually born with a body burden
of less than 1 mg. On the other hand, iron, an essential
metal, is present in higher concentration in the fetal blood,
suggesting preferential transport and affinity for the fetus.
The higher level of total mercury and methyl mercury in
fetal blood shown here is consistent with several other
reports. Methyl mercury has aparticular affinity for the ner-
vous system, where it becomes concentrated and may be
associated with prenatal mercury toxicity. It must be con-
cluded, therefore, that each trace metal, whether toxic or
essential, has its own transplacental transport mechanism.
There are few, if any, generalities.
The mechanism for the transport of lead to the placenta
is notwell defined. There are several reasons forsuggesting
that lead transport may be a matter ofsimple diffusion from
maternal to fetal circulation. Forone, there is the close quan-
titative relationship between mother's blood levels and cord
blood levels. There does not seem to be any placental bar-
rier or enhancing mechanism. Secondly, the transfer oflead
from mother to fetus has been shown inexperimental models
(guinea pig) to be linearly related to umbilical cord blood
flow rate (14). As the fetus grows, the umbilical cord flow
rate also increases. It has also been shown in the human
placenta that as the fetus grows and the placenta matures,
the number of villi increase by branching and the cross-
sectional diameter ofthe villi decreases from about 170/m
early in gestation to about 40 ,m near term. This process
more than doubles the villus surface area from 2 m2 to 11
m2 at term (15), and at the same time fetal blood vessels
become more excentric, and the syncytiotrophoblastic layer
thins, so the distance between maternal and fetal blood
vessels decreases. The percentage of fetal cardiac output
that goes to the placentais a constant40 to 50% throughout
gestation, so the volume of cardiac output per weight of
fetus does not change greatly. The volume of cord blood
flow is directly related to size offetus (16). These observa-
tions are particularly relevant to assuring a constant flow
ofoxygen to the fetus as well as transplacental diffusion of
lead from mother to fetus.
There are few measurements oflead levels in fetal tissues
at different ages ofgestation. The largest number ofmeas-
urements in a single study were reported by Barltrop (17).
Animportantquestion is how earlyin gestation does transfer
oflead occur. The Barltrop study started with fetuses about
13 weeks ofage and extended to term. There is no reason
to believe transfer oflead does not occur earlier. This study
showedthatlead contentofthe brain andothertissues grows
with the increase in organ size, but lead concentration
changed very little (17). This was probably because maternal
blood lead was relatively constant. The fetuses were from
abortions from mothers in the general population.
Although the ratis probably the best-studied animal model
to date regarding biochemical effects of lead on the brain,
there are few studies to date regarding distribution oflead
in the neonatal rat brain or effect on function. Behavioral
effects have been demonstrated in rats with chronic post-
weaning exposure to as low as 50 ppm of lead acetate in
drinking water (18), but metabolic effects of lead on the
centrl nervous system and its distribution have not been
reported. Lead levels in the nervous system of rats intox-
icated for the first 8 months of life by lead acetate (0.2%
in drfinldng water) differed in various regions of the brain.
Lead levels were highest in the hypocampus and cerebral
neocortex (19).
There is also some experimental evidence to suggest that
the fetal brain may have greater sensitivity to lead toxicity
than the more mature brain. Rat pups readily develop
encephalopathy during the first few days oflife and resistance
to lead-induced neurotoxicity occurs after 18 to 20 days of
age (20,21). Holtzman and co-workers (21) propose that the
development ofresistance to lead encephalopathy is related
to the formation oflead-protein complexes in astrocytes that
sequester lead away from mitochondria. This role of lead-
proteincomplexingis similarto thatpostulatedinrenaltubu-
larepithelial cells as a mechanism for permitting the kidney
to excrete lead without cellular toxicity (22). The lead-protein
complexes or inclusion bodies are thought to contain a
number of richly acidic proteins (23). More recently, Egle
and Shelton (24) have identified the most abundant protein
component ofisolated inclusion bodies to be a constitutive
protein ofthe central nervous system, most abundant in the
cerebral cortex. In rat brain the protein was found to be
developmentally regulated. Only traces were detected 3 days
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after birth, but within 1 to 2 weeks adult levels were
achieved. These studies do suggest, therefore, thatthis cell-
ular mechanism to sequester lead is not present in the fetal
brain.
Experimental studies suggest that the immature endo-
thelial cells forming the capillaries of the developing brain
are less resistant to the effects oflead than capillaries from
mature brains and permit fluid and cations including lead to
reach newly formed components of the brain, particularly
astrocytes and neurons (25). Recently, Markovas and Gold-
stein (26) investigated the effects ofinorganic lead oncalcium,
phospholipid-dependent protein kinase (protein kinase C)
in brain microvessels from 6-day-old rat pups. They found
that micromolar concentrations oflead activate this enzyme
to an extent equivalent to micromolar calcium, suggesting
this may be a very sensitive mechanism for cellular toxicity
in capillaries by lead, resulting in a breakdown in the nor-
mally tight blood-brain barrier.
Lead alters other calcium-mediated cellular processes
(2?28) and may also be associated with transplacental
transport ofcalcium. Barltrop (17) observed that femurlead
increased rapidly in the third trimester, corresponding to
onset of ossification and deposition of calcium. There is a
question whether the increased deposition of lead in the
femur along with calcium is due to some commonality be-
tween lead and calciummetabolism. Calciumdeficiency does
enhance lead absorption and the pathological effects oflead
(29). The placenta does contain a calcium-binding protein
identical to that present in the intestine (30). A recent com-
parison ofplacental transfer oftoxic metals by Nakano and
Kurosa from the Minamata Institute inJapan (unpublished
communication) found that lead levels in the placenta were
strongly correlated "with levels ofelements related to bone
metabolism suggesting thatplacental lead maybe associated
with calcification of this tissue."
Toxic effects oflead on placental function or morphology
have not been documented, but with toxic levels of lead
changes must occur. Lead has been used as an abortifa-
cient, and toxicity results in miscarriages. In experimental
animals including rats, toxic levels reduce the number of
viable offspring, and offspring are smaller than normal (31).
Placentas from lost fetuses are resorbed, but associated
placental toxicity has not been studied.
There are several reports ofplacenta lead concentrations
in the literature (32-34). Since the placenta is mostly
maternal and fetalblood, it might be expected that the lead
content would be equivalent to blood levels unless there
are foci ofconcentration. But values in various reports are
quite variable, mostly higher than blood values. There are
two possible explanations of this. For one, there may, in
fact, be alead-concentrating mechanism in some component
of the placenta, in trophoblasts for instance, but this has
not been demonstrated, and from what is known about
mechanisms for transplacental transport oflead, this is un-
likely. A second explanation seems more likely, that lead
is precipitated in the term placenta along with calcium. As
vili age they become necrotic, scarred with fibrous tissue,
and may contain fociofcalcium deposition. This would pro-
vide considerable samplingvariability, which maybe another
factor contributing to inconsistent findings.
Aninteresting set ofvalues is provided in a paperby Khera
and co-workers (35) concerning placenta lead values in
women in lead industries. Normal placental levels of lead
were found to be 0.29 + 0.9/tg/g, whereas lead in placentas
from stillborns was 0A5 + 0.32 .tg/g. Normals were defined
as no occupational exposure to lead for the 2 years prior
delivery. Nevertheless, these values are higher than the
generalpopulation. Stillborns as a group were even higher,
perhaps because of more calcium-lead precipitation in the
placenta. Finally, as might be expected, increase in lead in
the placenta was related to length ofoccupational lead expo-
sure and age. Measurements of lead in amniotic fluid and
fetal membranes are also quite variable and are, generally,
higher than the placenta, but the significance ofthis, ifany,
is not known.
In summary, there is no apparent maternal-fetal barrier,
to lead. Fetal blood lead levels are nearly equal to maternal
blood lead levels. The primary mechanism fortransplacen-
tal lead transport is probably simple diffusion and is prob-
ably related to fetalbloodflow rate. Itis suggested, however,
that fetaltissue levels may be influenced by calciumtransport
and intracellular calcium metabolism. On the other hand,
lead may alter calcium-mediated cellular processes, produc-
ing toxicity.
Lead concentration of developing fetal tissues including
the brainis related to the levelofbloodlead andis generally
constant throughout fetal life. Lead content increases with
brain size. There is currently noinformation, however, about
changes in regional distribution of brain lead during
development.
Fetal brain may be more susceptible to lead toxicity. The
blood-brain barrier is immature and does not provide any
barrier to lead entry into the brain. Also, there is some
evidence that formation oflead-protein complexes, a mech-
anism for sequestering lead in mature tissues, is not func-
tioning in fetal brain.
Finally, we must depend on animal model for estimating
risk for intrauterine lead toxicity; data from human fetuses
are notavailable. Primates are the best model forquantitative
data; rats may be the most practical model for determnining
mechanisms of toxicity.
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